Riskpilot← Back to searchSign inGet full accessConsol AB
ABActiveOrg 5563672012Krokslättsgatan 7Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19898 employees
Revenue 2024
SEK 23,6M
+5% vs 2023
EBITDA margin
6.5%
+41% vs 2023
Equity ratio
54.3%
Financial strength
Net profit 2024
SEK 1,2M
+157% vs 2023
| Revenue | SEK 23,6M | +5% |
| EBITDA | SEK 1,5M | +41% |
| Net profit | SEK 1,2M | +157% |
| Total assets | SEK 11,7M | -1% |
| Equity | SEK 6,4M | +22% |
| Employees | 8 | — |
Legal name
Consol AB
Org number
5563672012
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
8 september 1989
Share capital
SEK 200 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna externa firmatecknarna
Company purpose
Bolaget skall bedriva utveckling och försäljning av produkter och tjänster relaterade till kontaktlinser och skötsel av kontakt- linser, utveckling och försäljning av andra ögonvårdsprodukter, konsult- och utbildningsverksamhet inom dessa områden, samt bedriva därmed förenlig verksamhet.
Address
Krokslättsgatan 7
Phone
+46317785000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 24 366 | 22 421 | 20 814 | 20 665 | 22 196 | 22 421 | 23 638 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −5 900 |
| EBITDA | 1 317 | 1 649 | 3 614 | 3 286 | 1 909 | 1 099 | 2 079 | 1 906 | 1 093 | 1 542 |
| Depreciation & amort. | −853 | −872 | −918 | −969 | −1 171 | −1 335 | −1 163 | −1 055 | −1 007 | −1 119 |
| EBIT | 464 | 777 | 2 696 | 2 317 | 738 | −236 | 916 | 851 | 86 | 422 |
| Net financials | −76 | −130 | −100 | −78 | −102 | −88 | −56 | −41 | −56 | −83 |
| Profit before tax | 15 | 692 | 1 585 | 1 573 | 265 | 30 | 809 | 1 060 | 589 | 1 485 |
| Tax | −15 | −167 | −370 | −362 | −62 | −8 | −171 | −224 | −138 | −324 |
| Net profit | 0 | 525 | 1 215 | 1 211 | 203 | 22 | 638 | 836 | 451 | 1 161 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12 420 | 11 868 | 13 798 | 14 372 | 14 975 | 12 234 | 12 900 | 12 624 | 11 853 | 11 747 |
| Equity | 2 519 | 3 044 | 3 759 | 4 970 | 5 173 | 4 195 | 4 833 | 5 370 | 5 221 | 6 382 |
| Long-term debt | 3 570 | 2 171 | 1 420 | 522 | 1 695 | 1 144 | 594 | 70 | 383 | 0 |
| Short-term debt | 3 336 | 3 704 | 4 658 | 4 252 | 3 108 | 2 250 | 2 778 | 2 739 | 2 363 | 2 625 |
| Total debt | 6 906 | 5 875 | 6 078 | 4 774 | 4 803 | 3 394 | 3 372 | 2 809 | 2 746 | 2 625 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20152024
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20152024
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
20152024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20152024
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20152024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Audit | Audit | 2022 | — | — |
MM External Signatory | External Signatory | 2022 | — | — |
ZM Auditor Substitute | Auditor Substitute | 2022 | — | — |
JO External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Consol AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Frisk | Audit | 0 companies |
| Malin Maria Morup | External Signatory | 0 companies |
| Zlatan Mitrovic | Auditor Substitute | 0 companies |
| Johan Olof Johnsson | External Signatory | 0 companies |
| Inger Maria Johnsson | Board of Directors | 0 companies |
| Christian Evert Ingemar Morup | Deputy Board Member | 0 companies |
| Jan-Olov Sigurd Johnsson | Chairman | 0 companies |